• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Adamis Pharmaceuticals Corp

CY3A:GR

Ticker Delisted

As of 14:52:50 ET on 12/18/2014.

Snapshot for Adamis Pharmaceuticals Corp (CY3A)

Open: 4.218 Day's Range: 4.218 - 4.331 Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for CY3A

No chart data available.
  • CY3A:GR 4.312
  • 1M
  • 1Y
0.000
Interactive CY3A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CY3A

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (03/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CY3A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CY3A

Adamis Pharmaceuticals Corporation is a bio-pharmaceuticals company. The Company develops and distributes specialty pharmaceutical products in the therapeutic areas of oncology, immunology, infectious diseases, allergy and respiratory. Adamis Pharmaceuticals offers its products to the healthcare industry.

Dennis J CarloPresident/CEODavid J MarguglioSenior VP:Corporate Development
Robert O HopkinsVP:Finance/CFOKaren K DanielsVP:Operations
More Company Profile & Key Executives for CY3A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil